Moolec Science SA Stock (NASDAQ:MLEC)
Previous Close
$0.86
52W Range
$0.75 - $3.25
50D Avg
$0.87
200D Avg
$1.07
Market Cap
$33.26M
Avg Vol (3M)
$24.48K
Beta
-0.54
Div Yield
-
MLEC Company Profile
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
MLEC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| CNTA | Centessa Pharmaceuticals plc |
| IPSC | Century Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| JANX | Janux Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| GPCR | Structure Therapeutics Inc. |
| RZLT | Rezolute, Inc. |
| INDP | Indaptus Therapeutics, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| FBRX | Forte Biosciences, Inc. |
| STTK | Shattuck Labs, Inc. |